Abstract
The Keap1 protein is the master modulator of Nrf2 pathway; moreover, it is the hub of such important processes as cancer, cell stress, inflammation, and chemio- and radio-resistance. That is why Keap1 has become an intriguing pharmacological target. Many recent data show that Keap1 interacts with HSP90 protein. In this study, we use ferulic acid (FA) as antioxidant and anti-inflammatory agent, able to relieve inflammatory response. It is known that treatment with 100 μg of FA can significantly decrease the oxidative stress, so it turns to be useful to study the antioxidant regulation. The RAW 264.7 cells transfected with si-Keap1 and LPS treated are the in vitro model used to study the effects of Keap1 silencing on HSP90 activities and the FA antioxidant modulation. Immunoblot data and qPCR analysis show that Keap1 is involved in HSP90 modulation and on anti-oxidative response. Keap1 silencing affects negatively COX2 activation; in fact western blot and qPCR analysis conducted on RAW 264.7 cells Keap1silenced highlight that LPS treatment does not induce COX2 activation. In addition, the FA anti-oxidative and modulatory effect is abolished in COX2 pathway. The same results are point out using human A549 cell line with an allelic mutation on Keap1 gene, and the protein results are partially inactive. This preliminary study points out that Keap1protein is involved in HSP90 and anti-oxidative pathway regulation.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Heat shock proteins (HSPs) are highly conserved and constitutively expressed molecules in the cell. They have been studied for a long time and were initially related mostly to heat stress (Geraci et al. 2003, 2004), although it soon became clear that they played many other roles. HSPs usually constitute about 5–10 % of the total protein in most cells, but their intracellular concentrations can be increased by stressors, e.g., increased temperature (fever), oxidative stress, ethanol, and infection that induce protein unfolding, misfolding, or aggregation (Bukau et al. 2016; Kriegenburg et al. 2012). They act as molecular chaperones or proteases and are localized in the cytoplasm and in various intracellular compartments. Recently, many studies have shown that there is a connection between Hsp90, inflammation, and cancer. Therefore, this chaperone has gained a particular position at the core of the scientific interest (Tukaj and Węgrzyn 2016). Hsp90 is a highly abundant molecular chaperone, essential for cell growth and survival; it regulates the function of various proteins including several protein kinases and transcription factors (Neckers and Ivy 2003; Chen et al. 2002). Inhibition of Hsp90 by using small-molecule inhibitors has been extensively studied for its therapeutic potential in targeting cancer cells and promoting apoptosis (Bucci et al. 2000). Hsp90 participates in stabilizing and activating more than 200 “client” proteins, including key signaling molecules such as nuclear transcription factors NF-κB, STATs, p53, and kinases (e.g., Raf/MEK/ERK, PI3K/AKT, and p38/ MAPK) (Edwards and Basler 2015). Thus, it regulates crucial cellular processes, e.g., inflammation, growth, survival, differentiation, and apoptosis (Trepel et al. 2010). Inflammation is a very complex and interconnected phenomenon, so the observation that the proteotoxic pathway guided by HSP90 interacts with the antioxidant one is very interesting. Inflammation causes the onset of oxidative stress and the activation of cellular signaling pathways like the one concerning the nuclear factor erythroid-derived 2-like 2 (NRF2) (Lin et al. 2019). Nrf2 is a member of a family of basic leucine transcription factors that binds to the promoter region of genes involved in redox regulation, proteostasis, DNA repair, prevention of apoptosis, iron and heme metabolism, and phase I, II, and III drug/xenobiotic metabolism (Keum and Choi 2014). The activation of this transcriptional factor is controlled at transcriptional and post-transcriptional level (Nguyen et al. 2004; McMahon et al. 2010). In response to different stimuli, Nrf2 is stabilized and moves to the nucleus where it activates the transcription of its target genes. Nrf2 is a modular protein that presents seven domains of homology to Nrf2-ECH (Neh), each of which performs different functions; in particular, the Neh2 domain interacts with Keap1 (Itoh et al. 1995; McMahon et al. 2004). Under physiological conditions, Keap1protein maintains low Nrf2 levels intracellular levels, having a half-life of 10–30 min. In conditions of oxidative stress, Keap1 is oxidized on the reactive and inactivated cysteine residues, while Nrf2 stabilizes and moves into the nucleus (Zhang and Hannink 2003). The Nrf2-sMaf complex binds, in a specific sequence manner, to the antioxidant response elements (ARE 5′-TGACXXXGC-3′) in the promoter region of the target genes (Dinkova-Kostova et al. 2015). The role of Keap1 in the regulation of Nrf2 lifetime is now well known, and it is also clear that many anti-inflammatory agents, especially ferulic acid, flavonoids, hydroxycinnamic acids, and tannins, are able to reduce the oxidative stress levels (Srinivasan et al. 2007). Our previous study carried out in RAW264.7 cells treated with LPS showed that the anti-inflammatory activity of ferulic acid depends on Keap1 (Giacomarra et al. 2020). HSP 90 and Nrf2 are the master regulators of cellular homeostasis under stressful conditions, and many studies put in evidence that Hsp90 and KEAP1 interact upon heat shock, leading to the activation of NRF2 (Niture et al. 2010), and that the environmental redox changes can induce heat shock genes (Liu et al. 2016). KEAP1/NRF2 pathway and the heat shock response are cytoprotective pathways that are trigged by a stress signal in the cellular environment (Talalay et al. 1988; McMahon et al. 2010; Zhang et al. 2011). So in this paper, we discuss results preliminary, but very intriguing: we analyze the effect of Keap1 silencing on HSP90 pathway in an in vitro model RAW264.7 cells treated with LPS and in A549, a Keap1 mutated adenocarcinoma cell line (Singh et al. 2006).
Materials and methods
Cell culture and reagents
The mouse macrophage-like virus-transformed leukemia cell line RAW 264.7 was purchased from American Type Culture Collection (ATCC). RAW 264.7 cells and A549 cell line (provided by Francesca Sardina e Cinzia Rinaldo (IBPM-CNR, Roma, Italy) were cultured in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% v/v heat-inactivated fetal bovine serum (FBS) and antibiotics (100 U/ml penicillin and 100 μg/ml streptomycin) at 37°C in a humidified atmosphere with 5% CO2. FBS, DMEM, penicillin, and streptomycin (10,000 U/ml) were purchased from GIBCO (Grand Island, NY). LPS from E. coli serotype O55:B5 and ferulic acid (FA; CAS Number: 537-98-4) were purchased from Sigma-Aldrich, Inc. (St. Louis, MO). TRIzol was purchased from Invitrogen, the QuantiNova RT PCR kit from Hilden, Germany, and BrightGreen 2X qPCR MasterMix-ROX from abm (Canada). Nitrocellulose blotting membrane was purchased from Amersham Protran (Buckinghamshire, UK).
RT-qPCR
RAW 264.7 cells were cultured (1 ×106 cells/well) in a 6-well plate overnight. Cells were treated with 100 ng/ml LPS or without (negative control) in the presence or absence of 100 μM ferulic acid in DMEM supplemented with 10% bovine serum for 4 h. Cells stimulated with 100 ng/ml LPS for 4 h served as a positive control. After 4 h of stimulation, the cells were detached from the wells and washed once with PBS. Total RNA was isolated with TRIzol according to the manufacturer’s instructions and was quantified by UV absorbance spectrophotometry and reverse transcribed with QuantiNova RT PCR kit. QPCR was performed in triplicate on each cDNA sample for each gene using BrightGreen 2X qPCR MasterMix-ROX:
-
Hsp90 NM005348.2 F: 5′-CGATGAATATGCCATGACT-3′
-
R: 5′-TCCATAGCAGATTCTCCAG-3′
-
-
COX2 GI:31981524 F:5′-CAGACAACATAAACTGCGCCTT-3′
-
R: 5′-GATACACCTCTCCACCAATGACC -3′
-
-
HPRT NM194 F:5′-GCTATAAATTCTTTGCTGACCTGCTG-3′
-
R: 5′-AATTACTTTTATGTCCCCTGTTGACTGG-3′
-
by using primers set Quantitect from Qiagen. The threshold cycle (CT) values were calculated against the housekeeping gene Hprt. In order to report of results, all data were normalized to Hprt, which was assigned an arbitrary expression level of 10,000, and relative gene expression values were calculated by the following formula: relative expression 10,000/2 CT, where CT (gene CT/Hprt CT). Melt curve analysis was conducted to verify the purity and size of the resultant PCR products. At least three distinct biological samples were examined for each gene and treatment (each one performed in triplicate).
siRNA transfection
The RAW264.7 cells (5 × 105 cells/well) were seeded in 6-well plates for 24 h. Briefly, the siRNA pool for Keap1 (Qiagen) and NC-siRNA (Qiagen) were incubated with Lipofectamine RNAiMAX (Promega) in basal media with no serum or antibiotics and allowed to complex for 10 min at room temperature. Then, the complex was added to the cell suspension of each well (final siRNA pool concentration of 10 nM). Finally, cells were incubated for 24 h in a humidified incubator and then used for the analysis.
Western blotting
RAW 264.7 cells (1×107 cells) were cultured in 10-cm dishes (Falcon) and allowed to adhere for 24 h. After treatment with FA 100μM 1 followed by co-incubation with LPS 100 ngr/ml for 4 h, the cells were washed twice with cold PBS. Whole-cell lysates were obtained using RIPA buffer (Cell Signaling Inc. Beverly, MA, USA). The protein concentration of cell lysates was determined by the Bradford method. An amount of protein (30 μg) was separated on 8–16% Tris-Glycine Gel (BioRad) gels by electrophoresis and transferred to a nitrocellulose membrane. The membranes were subsequently incubated for 1 h at room temperature with 3% BSA in TBS buffer (0.1% v/v) to block non-specific binding and incubated with an appropriate primary antibody in 1% BSA in TBST (tween 0.01% v/v). Antibodies polyclonal anti-mouse recognizing HSP90, lamin B1, Keap1, COX2, and β-actin were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Incubation with the secondary antibodies Alexa Fluor 680 goat anti-rabbit (1:2000) and Alexa Fluor 800 rabbit anti-mouse (1:5000) (Molecular Probes, Life Technologies, Carlsbad, CA, USA) was performed for 1 h at room temperature. Densitometry analysis was conducted using the Odyssey Infrared Imaging System (Li-COR Bioscience, NE, USA).
Statistics
Statistical analysis
All data were analyzed by the one-way analysis of variance (one-way ANOVA) compared with the respective control group, followed by the multiple comparison test of Tukey’s, using the OriginPro 7.5 statistical program with the level of significance set to P < 0.05. Each result is reported as the mean of three independent replicate experiments ±SE.
Results
siRNA-mediated Keap1 knockdown alters HSP90 activity in RAW264.7 cells
Heat shock proteins (HSPs) are molecular chaperones produced in response to oxidative stress (OS), and there is evidence implicating heat shock protein 90 as a mediator of activation by bacterial lipopolysaccharide. In order to assess if Keap1-Cullin 3 pathway is related with HSP90 activity, we transfected the macrophage-like RAW 264.7 cells with siRNAs for Keap1 and uncorrelated siRNA. Moreover, immunoblot analysis was conducted to verify the protein level of HSP90; 24 h after transfection, cells were exposed to 100 ng/ml LPS for 4 h, and 1 h before LPS, the cells were treated or not with 100 μM FA. Several studies have already pointed out that 100 μM is a non-cytotoxic and antioxidant useful dose of FA to modulate the oxidative stress induced by LPS. Total protein extracts were prepared and analyzed in immunoblotting for Hsp90. Figure 1a shows that in RAW 264.7 cells transfected with uncorrelated siRNA, the Hsp90 level protein increases after LPS treatment, and FA is able to reduce such increase; instead, in the siRNA-mediated Keap1 knockdown, the FA modulation on LPS inducted HSP90 increase activity does not occur. Another important aspect was deeply focused on the regulation of hsp90a transcription. In the same system, we have also analyzed the expression of hsp90 mRNA to investigate the effects of siRNA-mediated Keap1 knockdown on activation of the hsp90 mRNA transcription: the qPCR analysis highlights that in RAW 264.7 cells transfected with uncorrelated siRNA, LPS significantly triggers the hsp90 mRNA transcription, and FA treatment reduces the mRNA level (Fig. 1b). On the contrary, in RAW 264.7 cells transfected with siRNAs for Keap1, LPS is not able to induce an increase of hsp90 mRNA level, despite the LPS activation. These results disclose an unrecognized mechanism which contributes to connect Keap1 and HSP90.
HSP90 regulation of anti-oxidative pathway is Keap1-mediated
HSP90—as a molecular chaperone—supports the active conformational structure and function of several signal proteins, termed “client” proteins; some of them are involved in cancer and inflammation. The COX-2 is known as prostaglandin-endoperoxide synthase (PTGS), an enzyme which is responsible for the formation of key biological mediators such as prostanoids (prostaglandins, prostacyclin, and thromboxane). It exists as two distinct isoforms (Kraemer, Hinz). COX-2 is inducible and expressed by cells that are involved in inflammatory processes. We used the RAW264.7 cells transfected with siRNA Keap1 to study the COX2 activity and evaluate the HSP90 regulation on this activity. QPCR analysis of COX2 mRNA expression showed in Figure 2a indicates that the level of COX2 mRNA does not increase in RAW264.7 cells Keap1 silencing unlike the uncorrelated RNA-transfected cells, despite LPS stimulus occurs. The results emerged from immunoblot analysis (Fig. 2b) put in evidence that FA does not modulate the COX2 protein activity when Keap1 is inactivated. Therefore, these results imply that the HSP90 regulation on anti-oxidative pathway is Keap1-mediated.
Study of HSP90 activity in A549 cell line
A549 cells are adenocarcinomic human alveolar basal epithelial cells carrying a homozygous Keap1 mutation (G333C) that alters binding with Nrf2. We used the A549 lung cancer cell line to verify that HSP90 regulation on COX2 requires active Keap1. Total protein and RNA were extracted from A549 cells exposed to 100 ng/ml LPS for 4 h and 1 h before LPS the cells were treated or not with 100 μM FA. Immunoblot and qPCR analyses were conducted. The analysis of HSP90 and COX2 level protein is shown in Figure 3a: the differences of HSP90 protein level in each group are not significant, and the same can be highlighted in immunoblot for COX2 protein. These data are confirmed by qPCR analysis of mRNA both for Hsp 90 and COX2. The amplification of cDNA with specific primers for Hsp90, COX2, and HPRT as internal standard showed that the transcription of HSP90 and COX2 mRNA does not increase also in LPS treated cells. These data indicate that in A549 cells in which Keap1 has an inactivating mutation, HSP90 and antioxidant pathways are altered. It can be assumed that Keap1 is an important redox-sentinel, and its function is necessary to activate properly the anti-oxidative pathway.
Discussion
The two most important molecular pathways involved in the antioxidant defense and in the cytoprotective activities are the Nrf2/Keap1 and Heat Shock pathways. In our previous paper (Giacomarra et al. 2020), we highlighted that Keap1 has an important role not only as a modulator of Nrf2, but it is able to modulate the transcription and protein expression of IKKβ, even if the mechanism is not fully clear. In addition, Keap1 is also required for the molecular mechanism underlying the anti-inflammatory effect of ferulic acid. In this study, we demonstrate that Keap1protein plays an important role in the regulation of HSP90 activity. The molecular approach based on silencing of Keap1 in RAW264.7 cells shows that HSP90 activation does not occur; in fact the mRNA expression is deeply altered. We used macrophage-like LPS-stimulated RAW264.7 cells, since such macrophages have vital roles in regulating inflammatory and antioxidant responses and A549—a lung adenocarcinoma cell line—owing to its point mutation in the Keap1 allele (Singh et al. 2006). For this reason, A549 cell line represents a useful model to study the effects of Keap1 loss of functionality. Our data show that when Keap1 is silenced or mutated, the cell is most susceptible to the oxidative damage, in that the anti-oxidative defense is less active, as demonstrated by the lower activation of COX2. COX2 is a very important antioxidant enzyme, and its activation occurs when there are pro-inflammatory conditions (Hinz and Brune 2002; Mohammadi et al. 2016; Kraemer et al. 1992). Our observations suggest a strong cooperative effect between the Keap1 and HSP90 proteins. The cooperativity effect exists because the two proteins are required to activate appropriately COX2 and the reciprocal interactions of HSP90 and Keap1 activities represent a regulatory loop able to influence the response to stressful agents (Fig. 4). The qPCR analysis carried out in Keap1 silenced and LPS treated RAW 264.7 cells showed that the COX2 activation does not occur. The most recent researches have highlighted that Keap1 is not only the repressor of Nrf2 but the most important molecular redox-sensor in the cell (Itoh et al. 2004; Satoh et al. 2006). The scaffold formed by the cysteine-stretch are the nucleus of redox sensor activities. Modifications into the cysteine-stretch in fact alter the Keap1 functionality (Saito et al. 2015). Our data are in line with the literature since they prove that Keap1 protein is required for the cell to receive the stimuli of oxidative stress and then to activate HSP90 protein. The same effect was observed in A549 cells treated with LPS. Many studies point out that Keap1 protein is not only the modulator of Nrf2 pathway but is the crucial point of connection between many pathways, such as the heat shock and antioxidant pathways (Kopacz et al. 2020). The present study is a little contribution to that. Furthermore, the observation that FA is not effective as antioxidant agent in Keap1 silenced RAW264.7 cells—when LPS treatment occurs—is an important scientific evidence, as some previous studies show too (Lampiasi and Montana 2018). It is already proved that Keap1 interacts with IKK chinase (Bloom et al. 2019), and the antioxidant/anti-inflammatory mechanism played by a lot of phenolic natural molecules is mediated by IKK chinase activity (Zeng et al. 2015; Lee et al. 2015). Consequently, we suppose that the fall in the FA effectiveness is linked to the altered interaction between IKK chinase activity and Keap1. As the activity of hsp90a promoter is regulated by NF-κB transcription factors (Ammirante et al. 2008), it can be assumed that the modifications in Keap1protein alter the cell defense machinery. Our results highlight that Keap1 protein is the key point of the linkage between oxidative stress and heat shock response, and we can speculate that in oxidant conditions, Keap1 is the molecular transductor of chemical stimuli into activation of molecular pathway such as the HSP90 protein. We proved that HSP90 activity was strongly inhibited by Keap1 alteration also pro-inflammatory stimuli occurring. These outcomes elucidate the role of Hsp90 as a mechanistic link between inflammation and oxidative stress, since Hsp90 is one of the most important molecular chaperones controlling the client proteins activities and pathways (Hoter et al. 2018; Shukla and Pitha 2012).
References
Ahmeda SMU, Luo L, Akhileshwar N, Wang X, Tang X (2017) Nrf2 signaling pathway: pivotal roles in inflammation. Biochim Biophys Acta (BBA) - Mol Basis Dis 1863:585–597 https://doi.org/10.1016/j.bbadis.2016.11.005
Ammirante M, Rosati A, Gentilella A, Festa M, Petrella A, Manzullo L, Pascale M, Belisario MA, Leone A, Turco MC (2008) The activity of hsp90a promoter is regulated by NF-κB transcription factors. Oncogene 27:1175–1178
Bloom MJ, Saksena SD, Swain GP, Behar MS, Yankeelov TE, Anna G, Sorace AG (2019) The effects of IKK-beta inhibition on early NF-kappa-B activation and transcription of downstream genes. Cell Signal 55:17–25. https://doi.org/10.1016/j.cellsig.2018.12.004
Bucci M, Roviezzo F, Cicala C, Sessa WC, Cirino G (2000) Geldanamycin, an inhibitor of heat shock protein 90 (Hsp90) mediated signal transduction has anti-inflammatory effects and interacts with glucocorticoid receptor in vivo. Br J Pharmacol 131:13–16
Bukau B, Weissman J, Horwich A (2016) Molecular chaperones and protein quality control. Cell 125:443–451
Chen G, Cao P, Goeddel DV (2002) TNF-induced recruitment and activation of the IKK complex require Cdc37 and Hsp90. Mol Cell 9:401–10
Dinkova-Kostova AT, Baird L, Holmström KM, Meyer CJ, Abramov AY (2015) The spatiotemporal regulation of the Keap1–Nrf2 pathway and its importance in cellular bioenergetics. Biochem Soc Trans 43(4):602–610
Geraci F, Agueli C, Giudice G, Sconzo G (2003) Localization of HSP70, Cdc2, and cyclin B in sea urchin oocytes in non-stressed conditions. Biochem Biophys Res Commun. 310(3):748–53. https://doi.org/10.1016/j.bbrc.2003.09.067
Geraci F, Pinsino A, Turturici G, Savona R, Giudice G, Sconzo G (2004) Nickel, lead, and cadmium induce differential cellular responses in sea urchin embryos by activating the synthesis of different HSP70s. Biochem Biophys Res Commun 322(3):873–7. https://doi.org/10.1016/j.bbrc.2004.08.005
Giacomarra M, Mangano A, Montana G (2020) The anti-inflammatory activity of ferulic acid on NF-κB depends on Keap1. LOJ Phar Cli Res 2(2)-LOJPCR.MS.ID.000133 https://doi.org/10.32474/LOJPCR.2020.02.000133
Hinz B, Brune K (2002) Cyclooxygenase-2 – 10 years later. J Pharmacol Exp Ther 300:367–375
Hoter A, El-Sabban ME, Naim HY (2018) The HSP90 family: structure, regulation, function, and implications in health and disease. Int J Mol Sci 19(9):2560. https://doi.org/10.3390/ijms19092560
Itoh K, Igarashi K, Hayashi N, Nishizawa M, Yamamoto M (1995) Cloning and characterization of a novel erythroid cell-derived CNC family transcription factor heterodimerizing with the small Maf family proteins. Mol Cell Biol 15(8):4184–93
Itoh K, Tong KI, Yamamoto M (2004) Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles. Free Radic Biol Med 36:1208–1213
Keum YS, Choi BY (2014) Molecular and chemical regulation of the Keap1-Nrf2 signaling pathway. Molecules 10;19(7):10074–10089 https://doi.org/10.3390/molecules190710074 Review
Kopacz A, Kloska D, Forman HJ, Jozkowicz A, Grochot-Przeczek (2020) A beyond repression of Nrf2: an update on Keap1. Free Radic Biol Med 157:63–74. https://doi.org/10.1016/j.freeradbiomed.2020.03.023
Kraemer SA, Meade EA, De Witt DL (1992) Prostaglandin endoperoxide synthase gene structure: identification of the transcriptional start site and 5’-flanking regulatory sequences. Arch Biochem Biophys 293:391–400
Kriegenburg F, Ellgaard L, Hartmann-Petersen R (2012) Molecular chaperones in targeting misfolded proteins for ubiquitin-dependent degradation. FEBS J 279:532–542
Lampiasi N, Montana G (2018) An in vitro inflammation model to study the Nrf2 and NF-κB crosstalk in presence of ferulic acid as modulator. Immunobiology 223(4-5):349–355 https://doi.org/10.1016/j.imbio.2017.10.046 Erratum in: Immunobiology. 2018 Oct;223(10):598
Lee J, Choi J, Kim S (2015) Effective suppression of pro-inflammatory molecules by DHCA via IKK-NF-κB pathway, in vitro and in vivo. Br J Pharmacol 172(13):3353–69. https://doi.org/10.1111/bph.13137
Lin X, Bai D, Wei Z, Zhang Y, Huang Y, Deng H, et al. (2019) Curcumin attenuates oxidative stress in RAW264.7 cells by increasing the activity of antioxidant enzymes and activating the Nrf2-Keap1 pathway. PLoS One 14(5):e0216711 https://doi.org/10.1371/journal.pone.0216711
Liu X, Jiang L, Liu F, Chen Y, Xu L, Li D, Ma Y, Li H, Xu J (2016) Effect of patchouli alcohol on the regulation of heat shock-induced oxidative stress in IEC-6 cells. Int J Hyperth 32(5):474–82. https://doi.org/10.3109/02656736.2016.1147617
McMahon M, Thomas N, Itoh K, Yamamoto M, Hayes JD (2004) Redox-regulated turnover of Nrf2 is determined by at least two separate protein domains, the redox-sensitive Neh2 degron and the redox-insensitive Neh6 degron. J Biol Chem 279:31556–31567
McMahon M, Lamont DJ, Beattie KA, Hayes JD (2010) Keap1 perceives stress via three sensors for the endogenous signaling molecules nitric oxide, zinc, and alkenals. Proc Natl Acad Sci USA 107:18838–18843
Edwards MR, Basler CF (2015) Marburg virus VP24 protein relieves suppression of the NF–κB pathway through interaction with Kelch-like ECH-associated protein 1. J Infect Dis 212:154–9
Mohammadi A, Yaghoobi MM, Gholamhoseinian NA, Kalantari-Khandani B, Sharifi H, Saravani M (2016) HSP90 inhibition suppresses PGE2 production via modulating COX-2 and 15-PGDH expression in HT-29 colorectal cancer cells. Inflammation 39(3):1116–23. https://doi.org/10.1007/s10753-016-0343-1
Neckers L, Ivy SP (2003) Heat shock protein 90. Curr Opin Oncol 15:419–424
Nguyen T, Yang CS, Pickett CB (2004) The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress. Free Radic Biol Med 15;37(4):433–441
Niture SK, Kaspar JW, Shen J, Jaiswal AK (2010) Nrf2 signaling and cell survival. Toxicol Appl Pharmacol 244(1):37–42. https://doi.org/10.1016/j.taap.2009.06.009
Raghunath A, Sundarraj K, Arfuso F, Sethi G, Perumal E (2018) Dysregulation of Nrf2 in hepatocellular carcinoma: role in cancer progression and chemoresistance. Cancers 10: 481 Dec 3;10(12):481 https://doi.org/10.3390/cancers10120481
Saito R, Suzuki T, Hiramoto K, Asami S, Naganuma E, Suda H, Iso T, Yamamoto H, Morita M, Baird L, Furusawa Y, Negishi T, Ichinose M, Yamamoto M (2015) Characterizations of three major cysteine sensors of Keap1 in stress response. Mol Cell Biol 36(2):271–84. https://doi.org/10.1128/MCB.00868-15
Satoh T, Okamoto S, Cui J, Watanabe Y, Furuta K, Suzuki M, Tohyama K, Lipton SA (2006) Activation of the Keap1/Nrf2 pathway for neuroprotection by electrophilic phase II inducers. Proc Nat Acad Sci USA 103:768–773
Shukla HD, Pitha PM (2012) Role of Hsp90 in systemic lupus erythematosus and its clinical relevance. Autoimmune Dis. https://doi.org/10.1155/2012/728605
Singh A, Misra V, Thimmulappa RK, Lee H, Ames S et al (2006) Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer. PLoS Med 3(10):e420. https://doi.org/10.1371/journal.pmed.0030420
Srinivasan M, Sudheer AR, Menon VP (2007) Ferulic acid: therapeutic potential through its antioxidant property. J Clin Biochem Nutr 40(2):92–100. https://doi.org/10.3164/jcbn.40.92
Talalay P, De Long MJ, Prochaska H (1988) Identification of a common chemical signal regulating the induction of enzymes that protect against chemical carcinogenesis. Proc Natl Acad Sci USA 85:8261–8265
Trepel J, Mollapour M, Giaccone G, Neckers L (2010) Targeting the dynamic HSP90 complex in cancer. Nat Rev Cancer 10(8):537–549. https://doi.org/10.1038/nrc2887
Tukaj S, Węgrzyn G (2016) Anti-Hsp90 therapy in autoimmune and inflammatory diseases: a review of preclinical studies. Cell Stress Chaperones 21:213–218. https://doi.org/10.1007/s12192-016-0670-z
Zeng KW, Yu Q, Song FJ, Liao LX, Zhao MB, Dong X, Jiang Y, Tu PF (2015) Deoxysappanone B, a homoisoflavone from the Chinese medicinal plant Caesalpinia sappan L., protects neurons from microglia-mediated inflammatory injuries via inhibition of IκB kinase (IKK)-NF-κB and p38/ERK MAPK pathways. Eur J Pharmacol 748:18–29. https://doi.org/10.1016/j.ejphar.2014.12.013
Zhang DD, Hannink M (2003) Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol Cell Biol 23:8137–8151
Zhang Y, Ahn YH, Benjamin IJ et al (2011) HSF1-dependent upregulation of Hsp70 by sulfhydryl-reactive inducers of the KEAP1/NRF2/ARE pathway. Chem Biol 18:1355–1361
Acknowledgements
Special thanks go to Nadia Lampiasi and Annalisa Pinsino for their helpful suggestions and precious advice. I warmly thank Prof Francesco Mineo for the careful language revision.
Funding
This project was supported by grants from the Public Education Department of Sicily Italy.
Author information
Authors and Affiliations
Contributions
A.B. carried out protein extractions and western blots and helped conceive the study.
M.G. cultured the cells and carried out western blots.
G. M. carried out qPCR experiments, as well as the transfection experiments, performed the statistical analysis, conceived the study, and wrote the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Bonura, A., Giacomarra, M. & Montana, G. The Keap1 signaling in the regulation of HSP90 pathway. Cell Stress and Chaperones 27, 197–204 (2022). https://doi.org/10.1007/s12192-022-01253-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12192-022-01253-5